Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Capricor Therap (NQ: CAPR ) 4.640 +0.060 (+1.31%) Streaming Delayed Price Updated: 12:41 PM EDT, Aug 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Capricor Therap < Previous 1 2 3 Next > Unveiling 6 Analyst Insights On Capricor Therapeutics July 02, 2024 Via Benzinga What's Going On With Capricor Therapeutics Stock Friday? June 28, 2024 The biotechnology company said deramiocel increased cardiac function based on several different measures. Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session June 11, 2024 Via Benzinga What's Going On With Capricor Therapeutics Stock Tuesday? June 11, 2024 Capricor Therapeutics announced successful completion of a Type-B meeting with the U.S. Food and Drug Administration (FDA). Via Benzinga What's Going On With Capricor Therapeutics Stock Tuesday? June 04, 2024 Capricor Therapeutics, Inc. (NASDAQ: CAPR) is trading higher Tuesday after the company announced three-year results from the ongoing HOPE-2 open-label extension Via Benzinga Expert Ratings For Capricor Therapeutics May 14, 2024 Via Benzinga Recap: Capricor Therapeutics Q4 Earnings February 29, 2024 Via Benzinga Earnings Scheduled For February 29, 2024 February 29, 2024 Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. Via Benzinga Capricor Therapeutics's Earnings Outlook February 28, 2024 Via Benzinga Preview: Capricor Therapeutics's Earnings November 13, 2023 Via Benzinga CAPR Stock Earnings: Capricor Therapeutics Misses EPS, Misses Revenue for Q1 2024 May 13, 2024 CAPR stock results show that Capricor Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace FlexShopper And 3 Other Penny Stocks Insiders Are Buying October 12, 2023 The Dow Jones closed higher by around 65 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying October 09, 2023 The Dow Jones closed higher by around 290 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities US Stocks Turn Lower; Dow Tumbles Over 200 Points September 29, 2023 U.S. stocks turned lower toward the end of trading, with the Dow Jones falling over 200 points on Friday. The Dow traded down 0.70% to 33,432.17 while the NASDAQ fell 0.15% to 13,181.22. The S&P 500... Via Benzinga Topics Stocks Exposures US Equities Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session September 29, 2023 Gainers Blue Apron Holdings, Inc. (NASDAQ: APRN) climbed 133.5% to $12.82 after the company announced an agreement to be acquired by Wonder Group for $13 per share. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session September 29, 2023 Via Benzinga Crude Oil Down 1% Following PCE Data; Blue Apron Shares Surge September 29, 2023 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Friday. The Dow traded up 0.13% to 33,710.74 while the NASDAQ rose 0.99% to 13,331.54. The S&P 500... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Nasdaq Gains Over 1%; Nike Posts Upbeat Earnings September 29, 2023 U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 1% on Friday. The Dow traded up 0.24% to 33,746.70 while the NASDAQ rose 1.22% to 13,362.51. The S&P 500 also rose,... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Friday's Pre-Market Session September 29, 2023 Via Benzinga Recap: Capricor Therapeutics Q1 Earnings May 11, 2023 Via Benzinga Earnings Preview For Capricor Therapeutics March 14, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session August 29, 2023 Via Benzinga Top 5 Health Care Stocks That May Fall Off A Cliff August 23, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga Earnings Scheduled For March 15, 2023 March 15, 2023 Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. Via Benzinga Capricor Highlights Preclinical Data From Its Closed COVID-19 Vaccine Study January 12, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022 October 26, 2022 Upgrades Via Benzinga Recap of Tuesday's Biotech Catalysts - End Of The Day Summary July 19, 2022 The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness... Via Benzinga Capricor Initiates Late-Stage Neuropsychiatric Disorder Study July 19, 2022 Capricor Therapeutics (NASDAQ: CAPR) initiated dosing of first patient in HOPE-3, a Phase 3 clinical trial investigating CAP-1002 for treating late-stage Duchenne muscular dystrophy (DMD). Via Benzinga More Than $27 Million Bet On Seres Therapeutics? 4 Penny Stocks Insiders are Buying July 08, 2022 U.S. stock futures traded lower this morning on Friday ahead of jobs report for june. Investors, meanwhile, focused on some notable insider trades. Via Benzinga 7 Undervalued Penny Stocks With Major Upside March 29, 2022 Each of these penny stocks has proven momentum throughout 2022 and major upside on top of the returns through the the first quarter. Via InvestorPlace < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.